An investigation investor in NASDAQ:IART shares over potential breaches of fiduciary duties by certain officers and directors of Integra LifeSciences Holdings Corp. was announced and NASDAQ: IART stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 03/21/2012 -- An investigation on behalf of investors in NASDAQ:IART shares was announced concerning potential breaches of fiduciary duties by certain officers and directors of Integra LifeSciences Holdings Corp. in connection with certain statements
Investors who purchased shares of Integra LifeSciences Holdings Corp. (NASDAQ:IART) and currently hold those IART shares, have certain options and should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Integra LifeSciences Holdings Corp. (NASDAQ:IART) concerning whether the company, certain of its officers and directors, or others have possibly violated federal securities laws. Specifically, the investigation concerns whether certain officers and directors of Integra breached their fiduciary duties to shareholders by permitting insufficient controls and improper procedures at one of the company's main collagen manufacturing facilities.
On October 31, 2011, Integra LifeSciences Holdings Corp. reported its third quarter 2011 results. Among other things, Integra LifeSciences Holdings said that its third quarter Net Income fell from $16.48million in 2010 to $11.24million in 2011. Integra LifeSciences Holdings Corp. also reaffirmed its FY 2011 revenue guidance but lowered its FY 2011 EPS guidance.
Then on Jan. 5, 2012, LifeSciences Holdings Corp reported its preliminary fourth quarter and full-year 2011 financial results and preliminary 2012 outlook. Among other things, LifeSciences Holdings Corporation also said that it received a warning letter from the United States Food and Drug Administration (“FDA”) related to quality systems and compliance issues at its collagen manufacturing facility located in Plainsboro, New Jersey. The letter resulted from an inspection held at that facility in August 2011.
Shares of Integra LifeSciences Holdings Corp fell from $30.80 on January 5th to $24.49 on Jan. 6, 2011. In fact, NASDAQ:IRAT shares fell from over $52 per share in April 2011 to as low as $23.22 on January 10, 2012.
Those who purchased shares of Integra LifeSciences Holdings (NASDAQ:IART) and currently hold those NASDAQ IART shares, may have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego